Virtus Investment Advisers, Inc. Amneal Pharmaceuticals, Inc. Transaction History
Virtus Investment Advisers, Inc.
- $112 Million
- Q2 2024
A detailed history of Virtus Investment Advisers, Inc. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 34,510 shares of AMRX stock, worth $295,060. This represents 0.2% of its overall portfolio holdings.
Number of Shares
34,510
Previous 34,510
-0.0%
Holding current value
$295,060
Previous $209,000
4.78%
% of portfolio
0.2%
Previous 0.16%
Shares
3 transactions
Others Institutions Holding AMRX
# of Institutions
187Shares Held
137MCall Options Held
234KPut Options Held
45.9K-
Ubs Group Ag21.8MShares$187 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$120 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$105 Million1.95% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$96.5 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$91.7 Million2.02% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.29B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...